Universal Nanovial Screening Enables Functional Discovery of Metabolite-Reactive T-Cell Receptors for Cancer Therapy.

Soemardy C, Li YR, Zhu Y, Shen X, Yang L, Di Carlo D.

Open source

DOI
10.1021/acsnano.5c22721
Published
2026-04-16
Container
ACS Nano
Publisher
Not recorded
Open access
no

Credibility signals

limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1021/acsnano.5c22721,
  title = {Universal Nanovial Screening Enables Functional Discovery of Metabolite-Reactive T-Cell Receptors for Cancer Therapy.},
  author = {Soemardy C and  Li YR and  Zhu Y and  Shen X and  Yang L and  Di Carlo D.},
  year = {2026},
  journal = {ACS Nano},
  doi = {10.1021/acsnano.5c22721},
  url = {https://doi.org/10.1021/acsnano.5c22721}
}

RIS

TY  - JOUR
TI  - Universal Nanovial Screening Enables Functional Discovery of Metabolite-Reactive T-Cell Receptors for Cancer Therapy.
AU  - Soemardy C
AU  -  Li YR
AU  -  Zhu Y
AU  -  Shen X
AU  -  Yang L
AU  -  Di Carlo D.
PY  - 2026
JO  - ACS Nano
DO  - 10.1021/acsnano.5c22721
UR  - https://doi.org/10.1021/acsnano.5c22721
ER  - 

APA

C, S., YR, L., Y, Z., X, S., L, Y., & D., D. C. (2026). Universal Nanovial Screening Enables Functional Discovery of Metabolite-Reactive T-Cell Receptors for Cancer Therapy.. ACS Nano. https://doi.org/10.1021/acsnano.5c22721

Source records